The Cancer Cure vs STANK
The Cancer Cure (DARAXONRASIB) and STANK (STANK) compared side by side. Over the past 7 days, DARAXONRASIB is ahead by 2.1 percentage points (DARAXONRASIB -17.6% against STANK -19.7%).
- Ahead over 7 days
- DARAXONRASIB
DARAXONRASIB 0.0%Share of the two combined market caps100.0% STANK
Performance
DARAXONRASIBSTANK
- 7 daysDARAXONRASIB
Risk & extremes
| Metric | DARAXONRASIB | STANK |
|---|---|---|
| Max drawdown (400d) | -43.3% | -58.7% |
| Risk-adjusted return (90d) | — | — |